Company Monitoring Page for JNJ

latest headlines for company on cafepharma

J&J agrees to pay about $1 billion to resolve hip implant lawsuits
Reuters
Wed, 05/8/19 - 05:32 pm
Tags:
JNJ, DePuy Synthes, Pinnacle Hip, metal-on-metal hip implants, devices
Watch out AbbVie and J&J, AstraZeneca just took another big swing at one of your star cancer drug franchises
Endpoints
Tue, 05/7/19 - 10:15 am
Tags:
AstraZeneca, Calquence, clinical trials, chronic lymphocytic leukemia, AbbVie, JNJ, Imbruvica
Where Will Johnson & Johnson Be in 10 Years?
Motley Fool
Sun, 05/5/19 - 06:50 pm
Tags:
JNJ
Marketing J&J eyes prostate cancer boost as FDA accepts Erleada for real-time review
Fierce Pharma
Fri, 05/3/19 - 10:43 pm
Tags:
JNJ, Erleada, FDA, prostate cancer, metastatic castration-resistant prostate cancer
J&J's quest to detect lung cancer before it emerges
Fierce Biotech
Thu, 04/25/19 - 11:40 am
Tags:
JNJ, smoking, lung cancer, MRNA, biomarkers
Arrowhead starts triple-combo hepatitis B test, triggering J&J payday
Fierce Biotech
Wed, 04/24/19 - 11:53 am
Tags:
Arrowhead Pharmaceuticals, JNJ, clinical trials, hepatitis B, ARO-HBV
What does the past generation of failure in Alzheimer’s R&D look like in one slide?
Endpoints
Wed, 04/24/19 - 11:45 am
Tags:
R&D, Alzheimer's disease, amyloid beta, Eli Lilly, Pfizer, JNJ
Investors to AbbVie, J&J, Merck and more: Fork over info on pricing and executive pay
Fierce Pharma
Tue, 04/23/19 - 05:32 pm
Tags:
AbbVie, Celgene, JNJ, Merck, Pfizer, Vertex Pharmaceuticals, investors, executive pay
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Fierce Pharma
Tue, 04/23/19 - 12:10 pm
Tags:
Bayer, JNJ, Xarelto, bloodthinners, Bristol-Myers Squibb, Pfizer, Eliquis
Most people pay less than $5 per month for the drug. But some pay $11,002
Stat
Wed, 04/17/19 - 09:45 am
Tags:
JNJ, Janssen, Stelara, drug pricing
Johnson & Johnson Rises After Topping First-Quarter Earnings Forecasts
TheStreet.com
Tue, 04/16/19 - 10:05 am
Tags:
JNJ, earnings
J&J, Merck and Pfizer spent tax savings on investor payouts, not R&D: Oxfam
Fierce Pharma
Mon, 04/15/19 - 11:30 am
Tags:
taxes, tax cuts, investors, R&D, Merck, JNJ, Pfizer
Forward Guidance Will Make or Break JNJ Earnings
NASDAQ
Mon, 04/15/19 - 09:55 am
Tags:
JNJ, earnings
Outracing 2 giant rivals, J&J touts promising PhIII Invokana data as a game-changer for kidney disease risks
Endpoints
Sun, 04/14/19 - 11:58 pm
Tags:
JNJ, Invokana, diabetes, kidney disease
Pfizer, AstraZeneca and J&J Take Issue With FDA’s List of Companies Withholding Drug Samples
RAPS.org
Fri, 04/12/19 - 11:46 pm
Tags:
generics, Pfizer, AstraZeneca, JNJ
J&J's Balversa gets accelerated approval for bladder cancer
BioCentury
Fri, 04/12/19 - 11:40 pm
Tags:
JNJ, Janssen, Balversa, bladder cancer, FDA
Going viral? J&J tries to spark a Twitterstorm for the latest data on its HIV med
Endpoints
Fri, 04/12/19 - 10:06 am
Tags:
JNJ, HIV, Symtuza, social media, twitter
The top 15 pharma companies by 2018 revenue
Fierce Pharma
Mon, 04/8/19 - 11:30 pm
Tags:
JNJ, Roche, Pfizer, Novartis, Merck, GSK, Sanofi, AbbVie, Bayer, Eli Lilly, Amgen, Bristol-Myers Squibb, Gilead Sciences, Teva Pharmaceutical, AstraZeneca
ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks
Pharmaceutical Business Review
Thu, 04/4/19 - 11:58 am
Tags:
ViiV Healthcare, Dolutegravir, rilpivirine, JNJ, Janssen, HIV
Eyeing a fast pitch for quick OK in race with bluebird, J&J/Legend team enjoys a regulatory embrace for their rival BCMA CAR-T
Endpoints
Thu, 04/4/19 - 11:53 am
Tags:
JNJ, Legend Biotech, JNJ-68284528, CAR-T, BCMA

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.